Biotech Values

[dewophile]

I was joking about the protocol that’s why I put novel in quotes. And any open label pain trial will show benefit because of the large placebo effects in such trials.
Amd yes even if they have clinical success the need is much lower when you have a less debilitating condition which probably can be managed for most with current alternatives
The company will spin the story and likely suck in some investors even though it is probably doomed from the start.
A generic makes more sense less costs and you can piggyback off all the existing data in a multitude of indications. I wonder if anyone has a generic Botox program